Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Interactions
  4. Cardiology
  5. Antihypertensives
  6. Beta-Blockers

Beta-Blockers

  • Bone & Joint (71)
  • Cardiology (293)
    • Antiarrhythmics (82)
    • Antihypertensives (93)
      • ACEIs (35)
      • Aldosterone Antagonists (14)
      • Alpha-Blockers (2)
      • ARBs (34)
      • Beta-Blockers (24)
      • Calcium Channel Blockers (36)
      • Diuretics (24)
    • Antiplatelets/Anticoagulants (145)
    • Dyslipidemia Drugs (72)
    • Other (21)
  • Dermatology (56)
  • Diabetes & Endocrinology (46)
  • Gastroenterology (87)
  • Hematology & Oncology (6)
  • Infectious Diseases (249)
  • Men's Health (3)
  • Natural Medicines / Supplements / Food Interactions (151)
  • Neurology (134)
  • Nutrition & Obesity (9)
  • Psychiatry (153)
  • Resources (44)
  • Respiratory & Allergy (16)
  • Transplant Meds (17)
  • Women's Health (53)
1 - 15 of 24 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Algorithm: Drug-Induced QT Prolongation: A Stepwise Approach
August 2022
Chart: Medications for Overactive Bladder May 2019
Patient Education: How to Use Eye Meds May 2018
Article: green tea may interfere with some meds March 2014
Commentary: OATP Drug Interactions March 2014
Article: Myrbetriq (meer-BEH-trick, mirabegron) for overactive bladder May 2013
PL Voices: Role of Myrbetriq (mirabegron) in Managing Overactive Bladder May 2013
Article: Patients who suffer from seasonal allergic rhinitis will be able to try SUBLINGUAL Oralair (ORR-ah-lair) February 2013
Commentary: New Drug: Oralair (Grass Pollen Allergen Extract) February 2013
Article: more alerts for drug and grapefruit interactions January 2013
PL Voices: How to Handle Drug Interactions with Grapefruit January 2013
Chart: Potential Drug Interactions with Grapefruit January 2013
Article: serious adverse events with Gilenya May 2012
Commentary: Safety Warnings for Gilenya (Fingolimod) May 2012
Commentary: QT Prolongation, Torsades de Pointes, & Medication Safety September 2011
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved